Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • FROM THE ANALYST'S COUCH

Demystifying industry–academia collaboration

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature Reviews Drug Discovery 18, 743-744 (2019)

doi: https://doi.org/10.1038/d41573-019-00001-2

Acknowledgements

The authors from ETH Zurich would like to acknowledge funding from the Swiss National Science Foundation (grant #146439).

Supplementary Information

  1. 41573_2019_CM16372872_MOESM1_ESM

Competing Interests

A.S., D.E. and H.W. are employees and shareholders of Novartis. G.K. is a former employee and current shareholder of Novartis. Novartis covered travel and data transcription expenses for the authors from ETH Zurich.

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links